CMRA

Comera Life Sciences Holdings, Inc.

0.25 USD
+0.20 (+490.36%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Comera Life Sciences Holdings, Inc. stock is up 250% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 February’s closed higher than January.

About Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease.